Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-26 @ 2:23 AM
Study NCT ID:
NCT05577702
Status:
COMPLETED
Last Update Posted:
2025-03-03
First Post:
2022-10-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-23
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-10
First Submit QC Date:
None
Study First Post Date:
2022-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-27
Last Update Post Date:
2025-03-03
Last Update Post Date Type:
ACTUAL